Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH casesEwa Pronicka, Mieczysław Litwin, Elżbieta Ciara et al.|Journal of Applied Genetics|2017Cited by 94
Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencingElżbieta Ciara, Ewa Pronicka, Dariusz Rokicki et al.|Molecular Genetics and Metabolism Reports|2016Cited by 32
Long-term outcome of the survivors of infantile hypercalcaemia with <i>CYP24A1</i> and <i>SLC34A1</i> mutationsAgnieszka Janiec, Mieczysław Litwin, Paulina Halat-Wolska et al.|Nephrology Dialysis Transplantation|2020Cited by 28
Sodium‐glucose cotransporter type 2 channel inhibitor: Breakthrough in the treatment of neutropenia in patients with glycogen storage disease type 1b?Magdalena Kaczor, Dorota Wesół‐Kucharska, Milena Greczan et al.|JIMD Reports|2022Cited by 20
Clinical characteristics and long-term outcomes of patients with glycogen storage disease type 1b: a retrospective multi-center experience in PolandMagdalena Kaczor, Dariusz Rokicki, Dorota Wesół‐Kucharska et al.|Pediatric Endocrinology Diabetes and Metabolism|2022Cited by 13